Page last updated: 2024-08-17

triamcinolone acetonide and Cranial Nerve II Diseases

triamcinolone acetonide has been researched along with Cranial Nerve II Diseases in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (55.56)	29.6817
2010's	3 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ayyala, R	1
Böker, A; Brockmann, C; Eckstein, D; Heufelder, J; Joussen, AM; Riechardt, AI; Seibel, I; Zeitz, O	1
Chen, S; Huang, W; Jonas, JB; Wang, J; Zhang, X	1
Bordaberry, M; Marcon, IM; Marques, DL; Pereira-Lima, JC; Schmid, H	1
Budde, WM; Harder, B; Jonas, JB; Kamppeter, BA; Sauder, G; Spandau, UH	1
Baath, J; Crichton, A; Ells, AL; Kherani, A; Williams, RG	1
Chang, YC; Wu, WC	1
Cakir, H; Kaya, V; Perente, I; Tutkun, IT; Utine, CA; Yilmaz, OF	1
Burns, CL	1

Trials

1 trial(s) available for triamcinolone acetonide and Cranial Nerve II Diseases

Article	Year
Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy. Acta ophthalmologica, 2009, Volume: 87, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Optic Nerve Diseases; Orbit; Pilot Projects; Prospective Studies; Retreatment; Tomography, X-Ray Computed; Treatment Outcome; Triamcinolone Acetonide; Visual Fields	2009

Article

Year

Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy.

Acta ophthalmologica, 2009, Volume: 87, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Optic Nerve Diseases; Orbit; Pilot Projects; Prospective Studies; Retreatment; Tomography, X-Ray Computed; Treatment Outcome; Triamcinolone Acetonide; Visual Fields

2009

Other Studies

8 other study(ies) available for triamcinolone acetonide and Cranial Nerve II Diseases

Article	Year
August consultation #2. Journal of cataract and refractive surgery, 2018, Volume: 44, Issue:8 Topics: Aged; Ciliary Body; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Laser Coagulation; Male; Optic Nerve Diseases; Polypropylenes; Suture Techniques; Sutures; Trabeculectomy; Triamcinolone Acetonide	2018
Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment? American journal of ophthalmology, 2019, Volume: 208 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Choroid Neoplasms; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intravitreal Injections; Male; Melanoma; Middle Aged; Observation; Optic Nerve; Optic Nerve Diseases; Proton Therapy; Radiation Injuries; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Young Adult	2019
Intravitreal triamcinolone acetonide, retinal microglia and retinal ganglion cell apoptosis in the optic nerve crush model. Acta ophthalmologica, 2016, Volume: 94, Issue:5 Topics: Animals; Apoptosis; Biomarkers; Blotting, Western; Cell Count; Cell Survival; Disease Models, Animal; Female; Fluorescent Antibody Technique, Indirect; Glucocorticoids; Intercellular Adhesion Molecule-1; Intravitreal Injections; Microglia; Microscopy, Confocal; Nerve Crush; Nitric Oxide Synthase Type II; Optic Nerve Diseases; Rats, Sprague-Dawley; Retinal Ganglion Cells; Retinal Neurons; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha	2016
Triamcinolone acetonide-induced ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:4 Topics: Adult; Antihypertensive Agents; Diagnostic Techniques, Ophthalmological; Female; Glucocorticoids; Humans; Intraocular Pressure; Lasers; Nerve Fibers; Ocular Hypertension; Optic Disk; Optic Nerve Diseases; Tomography; Triamcinolone Acetonide; Uveitis	2006
Safety profile of intravitreal triamcinolone acetonide. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2007, Volume: 23, Issue:3 Topics: Aged; Aged, 80 and over; Anterior Chamber; Endophthalmitis; Follow-Up Studies; Glaucoma, Open-Angle; Glucocorticoids; Humans; Injections; Intraocular Pressure; Middle Aged; Optic Nerve Diseases; Paracentesis; Retinal Artery Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body	2007
Intravitreal triamcinolone acetonide for the management of papillophlebitis and associated macular edema. International ophthalmology, 2008, Volume: 28, Issue:4 Topics: Adult; Diagnosis, Differential; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Optic Disk; Optic Nerve Diseases; Phlebitis; Retinal Vein; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2008
Management of ocular complications of Vogt-Koyanagi-Harada syndrome. International ophthalmology, 2009, Volume: 29, Issue:1 Topics: Adolescent; Cyclosporine; Drug Therapy, Combination; Eye Diseases; Female; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Optic Nerve Diseases; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Ultrasonography; Uveomeningoencephalitic Syndrome; Vitreous Body	2009
Unusual ocular presentation of sarcoidosis. Annals of ophthalmology, 1976, Volume: 8, Issue:1 Topics: Adult; Female; Fundus Oculi; Humans; Optic Disk; Optic Nerve; Optic Nerve Diseases; Prednisone; Sarcoidosis; Triamcinolone Acetonide	1976